Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,230 public trials 3,233 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +55 more
Locations
  • Hoag Memorial Presbyterian Newport Beach, California, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Titan Health Partners Llc Dba Astera Cancer Care East Brunswick, New Jersey, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

NCT03505320

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +10 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCLA Medical Center Santa Monica, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Mass General / North Shore Can Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

Conditions
AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma, +34 more
Locations
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Illinois Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2

NCT07143604

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Research Site Chelyabinsk, Russia
  • Research Site Krasnoyarsk, Russia
  • Research Site Kuzmolovskiy, Russia
  • Research Site Moscow, Russia
View all 13 locations
View Trial Details

Related conditions